Since the early 1970s, the synergistic activity of an aminoglycoside with a cell wall-active agent has been predicted by determining the ability of an enterococcus to grow in the presence of high levels of the aminoglycoside (usually ≥2,000 μg/ml). However, a variety of media and concentrations of aminoglycosides has been used for this screening procedure. In the present study, we sought to optimize the agar dilution, broth microdilution, and disk diffusion tests used to detect high-level gentamicin and streptomycin resistance in enterococci. For dilution tests, brain heart infusion agar or broth gave the best growth and performance. For agar dilution, 500 μg of gentamicin per ml, 2,000 μg of streptomycin per ml, and an inoculum of 1 x 106 CFU/ml were optimal, while for broth microdilution, 500 μg of gentamicin per ml, 1,000 μg of streptomycin per ml, and an inoculum of 5 x 105 CFU/ml were best. Growth of more than one colony in the agar dilution test was determined to be the best indicator of high-level resistance. For disk diffusion, Mueller-Hinton agar, 120-μg gentamicin disks, and 300-μg streptomycin disks with breakpoints of no zone for resistance and ≥10 mm for susceptibility gave the best sensitivity and specificity if results for strains with zones of 7 to 9 mm are considered inconclusive, indicating that a broth or agar test should be performed to determine susceptibility or resistance.
|Original language||English (US)|
|Number of pages||11|
|Journal||Journal of clinical microbiology|
|State||Published - Nov 7 1995|
ASJC Scopus subject areas
- Microbiology (medical)